Literature DB >> 1671463

Serological identification of Escherichia coli O157 as cause of haemolytic uraemic syndrome in Netherlands.

H Chart, B Rowe, N vd Kar, L A Monnens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1671463     DOI： 10.1016/0140-6736(91)91222-g

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Haemolytic-uraemic syndrome in childhood: surveillance and case-control studies in Italy. Italian HUS Study Group.

Authors:  A Gianviti; F Rosmini; A Caprioli; R Corona; M C Matteucci; F Principato; I Luzzi; G Rizzoni
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

2.  Serological detection of verocytotoxin-producing Escherichia coli in patients with haemolytic uraemic syndrome in western Europe.

Authors:  H Chart; N C van der Kar; J J Tolboom; L M Monnens; B Rowe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-09       Impact factor: 3.267

3.  Frequency of enterovirulent Escherichia coli in diarrhoeal disease in The Netherlands.

Authors:  C M Rademaker; A C Fluit; M Jansze; W H Jansen; J H Glerum; J Verhoef
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-02       Impact factor: 3.267

4.  Fecal diagnostics in combination with serology: best test to establish STEC-HUS.

Authors:  Kioa L Wijnsma; Sheila A M van Bommel; Thea van der Velden; Elena Volokhina; Michiel F Schreuder; Lambertus P van den Heuvel; Nicole C A J van de Kar
Journal:  Pediatr Nephrol       Date:  2016-05-30       Impact factor: 3.714

5.  Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccines.

Authors:  E Konadu; J B Robbins; J Shiloach; D A Bryla; S C Szu
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.609
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.